Selection of patients for laparoscopic antireflux surgery

Digestive Diseases

Volumn 18, Issue 3, 2000, Pages 129-137

  Glaser, Karl ^a,d   Wetscher, Gerold ^b   Klingler, Anton ^b   Klingler, Paul ^b   Eltschka, Bernard ^a   Hollinsky, Christian ^a   Achem, Sami ^c   Hinder, Ronald ^c  

^a Surgical Department   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c MAYO CLINIC   (United States)

^d Akupunkturambulanz des Kaiserin Elisabeth Spitals   (Austria)

Author keywords

Gastroesophageal reflux disease; Indication; Laparoscopy; Medical therapy; Patient selection; Surgery

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; LIFESTYLE; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANIMALS; BARRETT ESOPHAGUS; ENDOSCOPY, GASTROINTESTINAL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HERNIA, HIATAL; HISTAMINE H2 ANTAGONISTS; HUMANS; LAPAROSCOPY; PATIENT SELECTION; POSTPRANDIAL PERIOD;

EID: 0034464105     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051386     Document Type: Review

References (94)

1. Laparoscopic Nissen fundoplication: Preliminary report
2. Minimally invasive antireflux surgery
3. Gastroesophageal reflux disease
4. Age: An important factor in Barrett's oesophagus
5. Severe peptic oesophagitis
6. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors
7. The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding
8. Study of 47 consecutive patients with peptic esophageal stricture compared with 3880 cases of reflux esophagitis
9. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas
10. Barrett's esophagus: Clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics
11. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease
12. Barrett's esophagus: Development of dysplasia and adenocarcinoma
13. Adenocarcinoma in Barrett's oesophagus: An overrated risk
14. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
15. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
16. The incidence of cancer in Barrett's esophagus vary according to series
17. Adeno-carcinoma arising in Barrett's esophagus
18. Progression-regression of Barrett's esophagus
19. Is their prevalence in patients with Barrett's esophagus overestimated?
20. Adenocarcinoma and Barrett's esophagus. An overrated risk?
21. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux
22. Gastroesophageal reflux-associated recurrent pneumonia and chronic asthma in children
23. Gastroesophageal reflux and asthma: A possible reflex mechanism
24. Gastroesophageal reflux in patients with asthma and chronic bronchitis
25. Respiratory complications of gastroesophageal reflux
26. Laryngeal granuloma secondary to gastroesophageal reflux
27. Epidemiology and natural history of reflux esophagitis
28. Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales
29. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
30. History of surgery of the esophagus
31. Inflammation of the lower third of the esophagus
32. Muscular equivalent of the lower esophageal sphincter
33. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy
34. Predictive relationship of hiatal hernia to reflux esophagitis
35. Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease
36. Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction
37. Effect of esophageal emptying and saliva on clearance of acid from the esophagus
38. Does healing of esophagitis improve esophageal motor function?
39. Circadian esophageal motor function in patients with gastroesophageal reflux disease
40. Laparoscopic partial posterior fundoplication improves poor esophageal contractility in patients with gastroesophageal reflux disease
41. Laparoscopic partial posterior fundoplication provides excellent intermediate results in GERD patients with impaired esophageal peristalsis
42. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia
43. Does delayed gastric emptying contribute to gastroesophageal reflux disease
44. Length of the distal esophageal sphincter and competency of the cardia
45. Abnormal antroduodenal motility after cholecystectomy
46. Gastroesophageal reflux disease is associated with enteric hormone abnormalities
47. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease
48. Die laparoskopische Toupet Fundoplikation bei Refluxpatienten mit gestöter Ösophagusmotilität
49. Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication
50. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux
51. A comparison of five maintenance therapies for reflux esophagitis
52. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
53. 2receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms
54. The medical treatment of reflux esophagitis: Role of antacids and acid inhibition
55. Ranitidine versus cimetidine in the healing of erosive esophagitis
56. A prokinetic approach to treatment of gastroesophageal reflux disease
57. Omeprazole in the treatment of erosive esophagitis, refractory to high dose of cimetidine
58. 2-receptor antagonists
59. 2-receptor antagonists
60. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The US Multicenter Study
61. The floppy Nissen fundoplication. Effective long-term control of pathologic reflux
62. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients
63. Patient satisfaction following laparoscopic and open antireflux surgery
64. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease
65. Laparoscopic Nissen fundoplication
66. Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication
67. Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett's columnar-lined lower esophagus
68. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy
69. Interaction of lower esophageal sphincter pressure and length of sphincter in the abdomen as determinants of gastroesophageal competence
70. Tailored antireflux surgery for gastroesophageal reflux disease: Effectiveness and risk of postoperative dysphagia
71. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
72. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized
73. Fiberoptic technique for 24-hour bile reflux monitoring. Standards and normal values for gastric monitoring
74. Respiratory symptoms in patients with gastroesophageal reflux disease following medical therapy and following antireflux surgery
75. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and Nissen fundoplication
76. Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility
77. Conservative treatment versus antireflux surgery in Barrett's esophagus: Long-term results of a prospective study
78. Alkaline gastroesophageal reflux: Assessment by ambulatory esophageal aspiration and pH monitoring
79. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade
80. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux
81. Surgery for uncomplicated gastroesophageal reflux
82. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis
83. Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy
84. Peptic strictures of the esophagus
85. Management of the patient with benign esophageal stricture
86. Laparoscopic antireflux surgery for the treatment of esophageal strictures refractory to medical therapy
87. Gastric acid hypersecretion in refractory gastroesophageal reflux disease
88. Epidemiology of columnar-lined esophagus and adenocarcinoma
89. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy
90. Regression and progression of Barrett's oesophagus after antireflux surgery
91. Photodynamic therapy in Barrett's esophagus: Reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer
92. Gastro-oesophageal reflux and respiratory disorders in adults
93. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy